Значение воспаления в развитии жесткости сосудистой стенки
https://doi.org/10.14412/1995-4484-2013-644
Аннотация
В статье рассматривается проблема жесткости артериальной стенки при ревматических заболеваниях. Показана роль воспаления в патогенезе увеличения сосудистой жесткости, рассмотрены ее механизмы на уровне изменения клеточных компонентов, клинические признаки ассоциации воспаления и артериальной жесткости и возможности ее уменьшения, поиск новых терапевтических стратегий снижения жесткости артериальных сосудов с помощью применения противоревматических препаратов.
Список литературы
1. <div><p>Boutouyrie P., Tropeano A.I., Asmar R. et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension 2002;39:10-5.</p><p>Laurent S., Katsahian S., Fassot C. et al. Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke 2003;34:1203-6.</p><p>Sutton-Tyrrell K., Najjar S.S., Boudreau R.M. et al. Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation 2005;111:3384-90.</p><p>Scuteri A., Najjar S.S., Muller D.C. et al. Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness. J Am Coll Cardiol 2004;43:1388-95.</p><p>Zieman S.J., Melenovsky V., Kass D.A. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol 2005;25:932-43.</p><p>Lakatta E.G., Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. Part I: aging arteries: a «set up» for vascular disease. Circulation 2003;107:139-46.</p><p>Lakatta E.G. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. Part III: cellular and molecular clues to heart and arterial aging. Circulation 2003;107:490-7.</p><p>Jacob M.P. Extracellular matrix remodeling and matrix metallo-proteinases in the vascular wall during aging and in pathological conditions. Biomed Pharmacother 2003;57:195-202.</p><p>Wang M., Lakatta E.G. Altered regulation of matrix metallopro-teinase-2 in aortic remodeling during aging. Hypertension 2002;39:865-73.</p><p>Galis Z.S., Khatri J.J. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 2002;90:251-62.</p><p>Wang M., Zhang J., Jiang L.Q. et al. Proinflammatory profile within the grossly normal aged human aortic wall. Hypertension 2007;50:219-27.</p><p>Csiszar A., Ungvari Z., Edwards J.G. et al. Aging-induced phenotypic changes and oxidative stress impair coronary arteriolar function. Circ Res 2002;90:1159-66.</p><p>Csiszar A., Ungvari Z., Koller A. et al. Aging-induced proinflam-matory shift in cytokine expression profile in coronary arteries. FASEB J 2003;17:1183-5.</p><p>Spinetti G., Wang M., Monticone R. et al. Rat aortic MCP-1 and its receptor CCR2 increase with age and alter vascular smooth muscle cell function. Arterioscler Thromb Vasc Biol 2004;24:1397-402.</p><p>Ishibashi M., Hiasa K., Zhao Q. et al. Critical role of monocyte chemoattractant protein-1 receptor CCR2 on monocytes in hypertension-induced vascular inflammation and remodeling. Circ Res 2004;94:1203-10.</p><p>Viedt C., Vogel J., Athanasiou T. et al. Monocyte chemoattractant protein-1 induces proliferation and interleukin-6 production in human smooth muscle cells by differential activation of nuclear factor-kappaB and activator protein-1. Arterioscler Thromb Vasc Biol 2002;22:914-20.</p><p>Pasceri V., Willerson J.T., Yeh E.T. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000;102:2165-8.</p><p>Venugopal S.K., Devaraj S., Yuhanna I. et al. Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation 2002;106:1439-41.</p><p>Mahmud A., Feely J. Arterial stiffness is related to systemic inflammation in essential hypertension. Hypertension 2005;46:1118-22.</p><p>Nagano M., Nakamura M., Sato K. et al. Association between serum C-reactive protein levels and pulse wave velocity: a population-based cross-sectional study in a general population. Atherosclerosis 2005;180:189-95.</p><p>Boos C.J., Lip G.Y. Elevated high-sensitive C-reactive protein, large arterial stiffness and atherosclerosis: a relationship between inflammation and hypertension? J Hum Hypertens 2005;19:511-3.</p><p>Patel R.S., Al Mheid I., Morris A.A. et al. Oxidative stress is associated with impaired arterial elasticity. Atherosclerosis 2011;218:90-5.</p><p>Park S., Lakatta E.G. Role of inflammation in the pathogenesis of arterial stiffness. Yonsei Med J 2012;53:258-61.</p><p>McEniery C.M., Spratt M., Munnery M. et al. An analysis of prospective risk factors for aortic stiffness in men: 20-year follow-up from the Caerphilly prospective study. Hypertension 2010;56:36-43.</p><p>Новикова Д.С., Попкова Т.В., Мач Э.С., Насонов Е.Л. Ригидность артерий — интегральный показатель сердечнососудистого риска у больных ревматоидным артритом. Науч-практич ревматол 2009;5:38-48.</p><p>Ребров А.П., Гайдукова И.З. Повреждение эндотелия и жесткость сосудистой стенки у больных псориатическим артритом. Саратов науч-мед журн 2009;5:544-8.</p><p>Никитина Н.М., Ребров А.П. Определение риска развития сердечно-сосудистых заболеваний у больных ревматоидным артритом. Тер арх 2009;6:29-33.</p><p>Takami T., Shigemasa M. Efficacy of various antihypertensive agents as evaluated by indices of vascular stiffness in elderly hypertensive patients. Hypertens Res 2003;26:609-14.</p><p>Munakata M., Nagasaki A., Nunokawa T. et al. Effects of valsartan and nifedipine coat-core on systemic arterial stiffness in hypertensive patients. Am J Hypertens 2004;17(11 Pt 1):1050—5.</p><p>Lunder M., Janfc M., Jug B., Sabovfc M. The effects of low-dose fluvastatin and valsartan combination on arterial function: A randomized clinical trial. Eur J Intern Med 2012;23:261—6.</p><p>Цома В.В. Возможности медикаментозной коррекции жесткости сосудов при дислипидемии. Междунар эндокринол журн 2008;6:18.</p><p>Maki-Petaja K.M., Hall F.C., Booth A.D. et al. Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy. Circulation 2006;114:1185—92.</p><p>Angel K., Provan S.A., Fagerhol M.K. et al. Effect of 1-year anti-TNF-a therapy on aortic stiffness, carotid atherosclerosis, and cal-protectin in inflammatory arthropathies: a controlled study. Am J Hypertens 2012;doi:10.1038/ajh.2012.12.</p><p>Mathieu S., Pereira B., Dubost J.J. et al. No significant change in arterial stiffness in RA after 6 months and 1 year of rituximab treatment. Rheumatology (Oxford) 2012;51:1107—11.</p><p>Capkin E., Karkucak M., Kiris A. et al. Anti-TNF-a therapy may not improve arterial stiffness in patients with AS: a 24-week follow-up. Rheumatology (Oxford) 2012;51:910-4.</p><p>Schillaci G., Bartoloni E., Pucci G. et al. Aortic stiffness is increased in polymyalgia rheumatica and improves after steroidtreatment. Ann Rheum Dis 2012;71:1151-6.</p><p>Martinez-Calatrava M.J., Largo R., Herrero-Beaumont G. Improvement of experimental accelerated atherosclerosis by chondroitin sulphate. Osteoarthr Cartilage 2010;18(Suppl 1):S12—S16.</p></div><br />
Рецензия
Для цитирования:
Noskov S.M., Zavodchikov A.A., Shirokova K.Yu., Krasivina I.G., Lavrukhina A.A. Значение воспаления в развитии жесткости сосудистой стенки. Научно-практическая ревматология. 2013;51(2):159-162. https://doi.org/10.14412/1995-4484-2013-644
For citation:
Noskov S.M., Zavodchikov A.A., Shirokova K.Yu., Krasivina I.G., Lavrukhina A.A. Significance of inflammation in the development of vascular wall stiffness. Rheumatology Science and Practice. 2013;51(2):159-162. (In Russ.) https://doi.org/10.14412/1995-4484-2013-644
Просмотров:
1047
Послать статью по эл. почте 